Back to SYRE
BlackRock, Inc. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
55
Latest value
$7K
Q3 2026
Peak value
$318.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.5M |
| Q4 2025 | $17K |
| Q4 2025 | $6.4M |
| Q4 2025 | $4.7M |
| Q4 2025 | $98.7M |
| Q4 2025 | $64.8M |
| Q4 2025 | $9K |
| Q4 2025 | $221K |
| Q4 2025 | $3.5M |
| Q4 2025 | $297K |
| Q4 2025 | $634K |
| Q4 2025 | $2K |
| Q1 2026 | $2.6M |
| Q1 2026 | $7K |
| Q1 2026 | $625K |
| Q1 2026 | $10.1M |
| Q1 2026 | $8.6M |
| Q1 2026 | $149.2M |
| Q1 2026 | $98.7M |
| Q1 2026 | $60K |
| Q1 2026 | $356K |
| Q1 2026 | $5.9M |
| Q1 2026 | $457K |
| Q1 2026 | $1.8M |
| Q1 2026 | $4K |
| Q2 2026 | $6.7M |
| Q2 2026 | $13K |
| Q2 2026 | $890K |
| Q2 2026 | $18.3M |
| Q2 2026 | $23.6M |
| Q2 2026 | $303.3M |
| Q2 2026 | $204.8M |
| Q2 2026 | $156K |
| Q2 2026 | $889K |
| Q2 2026 | $1.1M |
| Q2 2026 | $193K |
| Q2 2026 | $12.1M |
| Q2 2026 | $804K |
| Q2 2026 | $4.7M |
| Q2 2026 | $7K |
| Q3 2026 | $6.8M |
| Q3 2026 | $13K |
| Q3 2026 | $881K |
| Q3 2026 | $17.6M |
| Q3 2026 | $24.9M |
| Q3 2026 | $318.8M |
| Q3 2026 | $212.4M |
| Q3 2026 | $132K |
| Q3 2026 | $435K |
| Q3 2026 | $1.1M |
| Q3 2026 | $384K |
| Q3 2026 | $13.7M |
| Q3 2026 | $918K |
| Q3 2026 | $5.3M |
| Q3 2026 | $7K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7K | 77 | — | — |
| Q3 2026 | $5.3M | 60.0K | — | — |
| Q3 2026 | $918K | 10.3K | — | — |
| Q3 2026 | $13.7M | 153.7K | — | — |
| Q3 2026 | $384K | 4.3K | — | — |
| Q3 2026 | $1.1M | 12.7K | — | — |
| Q3 2026 | $435K | 4.9K | — | — |
| Q3 2026 | $132K | 1.5K | — | — |
| Q3 2026 | $212.4M | 2.39M | — | — |
| Q3 2026 | $318.8M | 3.58M | — | — |
| Q3 2026 | $24.9M | 279.8K | — | — |
| Q3 2026 | $17.6M | 198.0K | — | — |
| Q3 2026 | $881K | 9.9K | — | — |
| Q3 2026 | $13K | 144 | — | — |
| Q3 2026 | $6.8M | 76.9K | — | — |
| Q2 2026 | $7K | 76 | — | — |
| Q2 2026 | $4.7M | 53.4K | — | — |
| Q2 2026 | $804K | 9.1K | — | — |
| Q2 2026 | $12.1M | 136.2K | — | — |
| Q2 2026 | $193K | 2.2K | — | — |
| Q2 2026 | $1.1M | 12.7K | — | — |
| Q2 2026 | $889K | 10.0K | — | — |
| Q2 2026 | $156K | 1.8K | — | — |
| Q2 2026 | $204.8M | 2.31M | — | — |
| Q2 2026 | $303.3M | 3.42M | — | — |
| Q2 2026 | $23.6M | 265.7K | — | — |
| Q2 2026 | $18.3M | 206.3K | — | — |
| Q2 2026 | $890K | 10.0K | — | — |
| Q2 2026 | $13K | 144 | — | — |
| Q2 2026 | $6.7M | 76.0K | — | — |
| Q1 2026 | $4K | 76 | — | — |
| Q1 2026 | $1.8M | 35.9K | — | — |
| Q1 2026 | $457K | 9.1K | — | — |
| Q1 2026 | $5.9M | 117.5K | — | — |
| Q1 2026 | $356K | 7.1K | — | — |
| Q1 2026 | $60K | 1.2K | — | — |
| Q1 2026 | $98.7M | 1.96M | — | — |
| Q1 2026 | $149.2M | 2.96M | — | — |
| Q1 2026 | $8.6M | 171.0K | — | — |
| Q1 2026 | $10.1M | 200.4K | — | — |
| Q1 2026 | $625K | 12.4K | — | — |
| Q1 2026 | $7K | 144 | — | — |
| Q1 2026 | $2.6M | 52.4K | — | — |
| Q4 2025 | $2K | 76 | — | — |
| Q4 2025 | $634K | 19.4K | — | — |
| Q4 2025 | $297K | 9.1K | — | — |
| Q4 2025 | $3.5M | 106.1K | — | — |
| Q4 2025 | $221K | 6.8K | — | — |
| Q4 2025 | $9K | 277 | — | — |
| Q4 2025 | $64.8M | 1.98M | — | — |
| Q4 2025 | $98.7M | 3.01M | — | — |
| Q4 2025 | $4.7M | 144.0K | — | — |
| Q4 2025 | $6.4M | 196.4K | — | — |
| Q4 2025 | $17K | 513 | — | — |
| Q4 2025 | $1.5M | 46.3K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M